Bank Of America Corp Silence Therapeutics PLC Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Bank Of America Corp holds 499,066 shares of SLN stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
499,066
Previous 1,034
48165.57%
Holding current value
$2.25 Million
Previous $18,000
18972.22%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SLN
# of Institutions
66Shares Held
24.6MCall Options Held
500Put Options Held
5K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$13.7 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$12.7 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$10.8 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$8.35 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$7.48 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $161M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...